CN102085333B - Medicament for treating leucoderma - Google Patents

Medicament for treating leucoderma Download PDF

Info

Publication number
CN102085333B
CN102085333B CN2011100099371A CN201110009937A CN102085333B CN 102085333 B CN102085333 B CN 102085333B CN 2011100099371 A CN2011100099371 A CN 2011100099371A CN 201110009937 A CN201110009937 A CN 201110009937A CN 102085333 B CN102085333 B CN 102085333B
Authority
CN
China
Prior art keywords
parts
treatment
leukodermic medicine
radix
leukodermic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2011100099371A
Other languages
Chinese (zh)
Other versions
CN102085333A (en
Inventor
朱五元
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011100099371A priority Critical patent/CN102085333B/en
Publication of CN102085333A publication Critical patent/CN102085333A/en
Application granted granted Critical
Publication of CN102085333B publication Critical patent/CN102085333B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicament for treating leucoderma, which is prepared from 10 parts of angelica, 10 parts of radix paeoniae alba, 15 parts of motherwort, 10 parts of radix curcumae, 15 parts of wild rue, 15 parts of cocklebur fruit, 15 parts of tuckahoe and 15 parts of pyrite. The clinical treatment on thousands of patients indicates that the effective rate of leucoderma is 95%, and the cure rate is higher than 80%.

Description

The leukodermic medicine of a kind of treatment
Technical field
The present invention relates to the leukodermic medicine of a kind of treatment.
Background technology
Vitiligo is to take off to lose with skin pigment to present leukasmus or milky white mottle and gain the name.Skin pigment is a dermal melanin, and dermal melanin is present in skin and the intrafollicular melanocyte, and the melanin that melanocyte produces is converted into DOPA by tryrosinase under the tryrosinase effect, forms through a series of biochemical processes again.When this process generation obstacle, just cause that depigmentation is appearance day shift.
Traditional medicine thinks that though vitiligo is long in appearance, root is at internal organs.System is because of easypro in feelings will, disharmony between QI and blood, and blockage of the vessel is obstructed, and chosure of pores is due to the failure of skin and muscle to be nourished.Also skin is the mirror of internal organs just, and the disease of the vital organs of the human body all shows on the skin.
Vitiligo is diagnosed well, and refractory is healed, and leukodermic morbidity is on the rise.
Summary of the invention
Technical problem to be solved by this invention provides the leukodermic medicine of a kind of treatment.
The present invention adopts following technical scheme:
The leukodermic medicine of a kind of treatment adopts following component to make: 10 parts of Radix Angelicae Sinensis, 10 parts of the Radix Paeoniae Albas, 15 parts of Herba Leonuris, 10 parts of Radix Curcumaes, 15 parts of Fructus Tribulis, 15 parts of Fructus Xanthii, 15 parts in Poria, 15 parts of Pyritums.
Treating leukodermic medicine can be made into: oral liquid, and decoct, pill, granule, can also process outer liniment < tincture >: adding 65% jowar wine with the top, to soak after ten days bottling subsequent use, wipes the affected part every day three times.
The prescription effect:
Enrich blood, blood circulation promoting and blood stasis dispelling, speckle dispelling, the supplementation with copper ion, nourishing melanin generates.
Pharmaceutical analysis:
Radix Angelicae Sinensis: enrich blood, invigorate blood circulation, pain relieving, intestine moistening.
The Radix Paeoniae Alba: the yin fluid astringing that nourishes blood, easing the affected liver to relieve pain, suppressing liver-YANG
Herba Leonuri: blood circulation promoting and blood stasis dispelling, inducing diuresis to remove edema.
Radix Curcumae: promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, removing heat from blood clears away heart-fire, promoting the function of the gallbladder to alleviate jaundice.
Fructus Tribuli: the kidney invigorating, controlling nocturnal emission with astringent drugs, nourishing the liver to improve visual acuity.
Fructus Xanthii: clearing the nasal passage, wind-damp dispelling, pain relieving.
Poria: promoting diuresis to eliminate damp pathogen, spleen invigorating is calmed the nerves.
Pyritum: eliminating stasis to stop pain, whereabouts are for stagnating.
Clinical efficacy is to over thousands of routine therapy of vitiligo effective percentage 95% cure rate more than 80%.
The specific embodiment
Below in conjunction with specific embodiment, the present invention is elaborated.
Treat leukodermic medicine prescription: Radix Angelicae Sinensis 10 grams, the Radix Paeoniae Alba 10 grams, Herba Leonuri 15 grams, Radix Curcumae 10 grams, Fructus Tribuli 15 grams, Fructus Xanthii 15 grams, Poria 15 grams, Pyritum 15 grams.Can be made into: oral liquid, decoct, pill, granule, can also process outer liniment < tincture >: adding 65% jowar wine with the top, to soak after ten days bottling subsequent use, wipes the affected part every day three times.
Clinical efficacy is to over thousands of routine therapy of vitiligo effective percentage 95% cure rate more than 80%.
Du Jia village, Jia Qu township, case 1. Pucheng County, written elegant woman 34 years old suffers from vitiligo for many years, treats leukodermic medicine treatment two courses of treatment (30 days course of treatment) recovery from illness with the present invention.
Daylight village, macropore township, case 2. Pucheng County, gorgeous women 23 years old of Jiang Yan suffers from vitiligo.Treat two recoveries from illness course of treatment of leukodermic medicine treatment with the present invention.
Eternally happy village, town, the stingy shop of case 3. Weinan Cities, cloudy roc man suffered from vitiligo in 21 years old, treated three recoveries from illness course of treatment of leukodermic medicine treatment with the present invention.
Dang Ding village, Su Fang town, case 4. Pucheng County, the Jing Chao man suffered from vitiligo in 21 years old, treated five recoveries from illness course of treatment of leukodermic medicine treatment with the present invention.
Auspicious plateau village, case Dong Yang township, 5. Pucheng County, bavin ice man suffered from vitiligo in 16 years old, treated two recoveries from illness course of treatment of leukodermic medicine treatment with the present invention.
Chao Yi town, case 6. Dali County, Lu change gorgeous women 36 years old suffers from vitiligo, treats five recoveries from illness course of treatment of leukodermic medicine treatment with the present invention.
Should be understood that, concerning those of ordinary skills, can improve or conversion, and all these improvement and conversion all should belong to the protection domain of accompanying claims of the present invention according to above-mentioned explanation.

Claims (3)

1. the leukodermic medicine of treatment is characterized in that, adopts following component to make: 10 parts of Radix Angelicae Sinensis, 10 parts of the Radix Paeoniae Albas, 15 parts of Herba Leonuris, 10 parts of Radix Curcumaes, 15 parts of Fructus Tribulis, 15 parts of Fructus Xanthii, 15 parts in Poria, 15 parts of Pyritums.
2. the leukodermic medicine of treatment according to claim 1 is characterized in that the leukodermic medicine of said treatment adopts one of following dosage form: oral liquid, decoct, pill, granule, tincture.
3. the leukodermic medicine of treatment according to claim 2 is characterized in that, said tincture method for preparing is: said component is added the immersion of 65% jowar wine bottle subsequent use after ten days.
CN2011100099371A 2011-01-18 2011-01-18 Medicament for treating leucoderma Expired - Fee Related CN102085333B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011100099371A CN102085333B (en) 2011-01-18 2011-01-18 Medicament for treating leucoderma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011100099371A CN102085333B (en) 2011-01-18 2011-01-18 Medicament for treating leucoderma

Publications (2)

Publication Number Publication Date
CN102085333A CN102085333A (en) 2011-06-08
CN102085333B true CN102085333B (en) 2012-07-04

Family

ID=44097494

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011100099371A Expired - Fee Related CN102085333B (en) 2011-01-18 2011-01-18 Medicament for treating leucoderma

Country Status (1)

Country Link
CN (1) CN102085333B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1051460C (en) * 1993-09-09 2000-04-19 郭长香 Medicine for treatment of leukoderma and its preparing method
CN1162170C (en) * 2001-07-26 2004-08-18 刘双义 Leukoderma treating medicine and its prepn
CN100467050C (en) * 2005-12-22 2009-03-11 夏金陵 Composition formula for treating leucoderma and its preparation method
CN1840117A (en) * 2006-01-26 2006-10-04 葛强 Dermatosis-treating medicine

Also Published As

Publication number Publication date
CN102085333A (en) 2011-06-08

Similar Documents

Publication Publication Date Title
CN102327380B (en) Chinese medicinal composition for treating knee osteoarthritis
CN100336527C (en) Medicine for treating celevical vertebra disease
CN103446264A (en) Physical therapy liquid for treating neck-shoulder and lumbocrural pains and preparation method thereof
CN101983717A (en) Traditional Chinese medicine for treating migraine
CN102872301B (en) Anti-rheumatism medicinal liquor and using method thereof
CN103948768A (en) Traditional Chinese medicine preparation for treating rheumatism and rheumatoid arthritis
CN103784804A (en) Pharmaceutical composition for treating benign prostatic hyperplasia
CN103656042A (en) Medicine for treating herpes zoster
CN102406796A (en) Medicament for treating obesity of elderly people
CN103006997B (en) Medicine for treating post-craniotomy headache
CN102085333B (en) Medicament for treating leucoderma
CN102000166B (en) Medicinal liquor for treating rheumatic arthritis and chronic infectious arthritis
CN102327438A (en) Liquid for strengthening bone and alleviating pain
CN1236806C (en) Liver-tonifying stone-removing Chinese medicine
CN101856467A (en) Chinese medicament for treating bone fractures
CN1211118C (en) Formula of medication for treating bone fracture and contuse
CN105381098A (en) Traditional Chinese medicine fumigating and washing agent for treating knee osteoarthritis and nursing method
CN101244200A (en) Chinese medicine for treating mazopathy
CN103356957B (en) Medicine for treating stomach cancer and preparation method thereof
CN103877348A (en) Traditional Chinese medicine preparation for treating periostitis and preparation method thereof
CN102552617A (en) Medicine for treating acute waist sprain
CN107865959A (en) Treat the Chinese medicine of type of depression of QI biliary system infection
CN101683504A (en) Preparation method of relieved pill for activating blood circulation to dissipate blood stasis
CN105709009A (en) Externally-used traditional Chinese medicine pain-relieving liquid used for treating cervical spondylosis
CN108066519A (en) Treat the prescription of freckle

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120704

Termination date: 20130118

CF01 Termination of patent right due to non-payment of annual fee